erythropoietin

简明释义

英[ɪˌrɪθrəʊpɔɪˈiːtɪn]美[ɪˌrɪθropɔɪˈitɪn]

n. （促）红细胞生成素

英英释义

单词用法

同义词

反义词

例句

1.It has been proved that erythropoietin has neuroprotective effect and therapeutic action on cerebral ischemia in vivo and in vitro.

体外细胞培养及动物实验证明，促红细胞生成素对脑缺血损伤具有神经保护和治疗作用。

2.Erythropoietin, the principal regulator of erythroids progenitor cells, is widely used to treat anemia caused by many diseases.

促红细胞生成素是一种造血因子，临床中广泛应用于治疗各种原因造成的贫血。

3.Objective: To study the use of erythropoietin receptor (EPOR) in anemia of chronic renal failure.

目的：探讨促红细胞生成素受体（EPOR）在慢性肾功能衰竭肾性贫血中的表达及意义。

4.Objective To investigate the prevention effect of erythropoietin on chemotherapy-induced anemia.

目的探讨红细胞生成素对小鼠化疗所致贫血的预防作用。

5.Background: Erythropoietin is a naturally occurring hormone with multiple effects on a number of different cell types.

背景资料：促红细胞生成素是一种天然存在的激素，对能对各种不同的细胞发挥多种作用。

6.The IOC Medical Commission has approved a test to detect the use of the banned synthetic hormone erythropoietin, or EPO.

国际奥委会药物委员会已经通过了一项测试来检测违禁使用合成激素红细胞生成素（简称EPO）的情况。

7.The doctor explained that erythropoietin 红细胞生成素 is crucial for stimulating red blood cell production.

医生解释说，erythropoietin 红细胞生成素 对于刺激红血球的生成至关重要。

8.Patients with chronic kidney disease often have low levels of erythropoietin 红细胞生成素, leading to anemia.

慢性肾病患者通常有低水平的erythropoietin 红细胞生成素，这会导致贫血。

9.Athletes sometimes misuse erythropoietin 红细胞生成素 to enhance their performance.

运动员有时滥用erythropoietin 红细胞生成素来提高他们的表现。

10.The treatment involves administering synthetic erythropoietin 红细胞生成素 to boost red blood cell counts.

治疗涉及给予合成的erythropoietin 红细胞生成素以提高红血球计数。

11.Research shows that erythropoietin 红细胞生成素 can also have neuroprotective effects.

研究表明，erythropoietin 红细胞生成素也可能具有神经保护作用。

作文

Erythropoietin, often abbreviated as EPO, is a glycoprotein hormone that plays a crucial role in the regulation of red blood cell production in the body. It is primarily produced by the kidneys and acts on the bone marrow to stimulate the production of erythrocytes, which are essential for transporting oxygen throughout the body. The discovery of erythropoietin has had significant implications in both medicine and sports, particularly in the treatment of anemia and in the controversial practice of blood doping. Anemia is a condition characterized by a deficiency of red blood cells or hemoglobin in the blood, leading to fatigue, weakness, and other health issues. Patients suffering from chronic kidney disease often experience anemia due to reduced production of erythropoietin. In such cases, synthetic forms of erythropoietin can be administered to stimulate red blood cell production, improving the quality of life for these patients. This therapeutic use of erythropoietin has revolutionized the management of anemia, providing an effective solution for many individuals who previously had limited options. However, the role of erythropoietin extends beyond medical treatment. In the world of sports, erythropoietin has been misused as a performance-enhancing drug. Athletes have been known to inject synthetic erythropoietin to increase their red blood cell count, thereby enhancing their endurance and overall performance. This practice, known as blood doping, poses significant health risks, including increased blood viscosity, hypertension, and a higher likelihood of thromboembolic events. As a result, various sports organizations have implemented strict regulations and testing procedures to combat the abuse of erythropoietin in competitive sports. The ethical considerations surrounding the use of erythropoietin in sports highlight the complex relationship between science, medicine, and human behavior. While the hormone can provide legitimate medical benefits, its potential for misuse raises questions about fairness and integrity in athletics. The conversation surrounding erythropoietin serves as a reminder of the importance of maintaining ethical standards in both healthcare and sports. In conclusion, erythropoietin is a vital hormone that significantly impacts red blood cell production and, consequently, overall health. Its therapeutic applications in treating anemia have transformed patient care, while its misuse in sports has sparked ongoing debates about ethics and fairness. Understanding the dual nature of erythropoietin allows us to appreciate its contributions to medicine while remaining vigilant about its potential for abuse. As research continues to evolve, it is essential to strike a balance between harnessing the benefits of erythropoietin and ensuring its responsible use across all fields.

红细胞生成素，通常缩写为EPO，是一种糖蛋白激素，在体内红细胞生成的调节中发挥着至关重要的作用。它主要由肾脏产生，并作用于骨髓以刺激红细胞的生成，这对在全身运输氧气至关重要。红细胞生成素的发现对医学和体育领域产生了重大影响，特别是在贫血的治疗和血液兴奋剂的争议性实践中。 贫血是一种以血液中红细胞或血红蛋白缺乏为特征的疾病，导致疲劳、虚弱和其他健康问题。患有慢性肾病的患者往往由于红细胞生成素的产生减少而出现贫血。在这种情况下，可以施用合成形式的红细胞生成素来刺激红细胞的生成，从而改善这些患者的生活质量。红细胞生成素的这种治疗用途彻底改变了贫血的管理，为许多之前选择有限的个体提供了有效的解决方案。 然而，红细胞生成素的作用不仅限于医疗治疗。在体育界，红细胞生成素被滥用作为一种增强运动表现的药物。运动员已知会注射合成的红细胞生成素以增加他们的红细胞数量，从而提高耐力和整体表现。这种做法被称为“血液兴奋剂”，带来了显著的健康风险，包括血液粘稠度增加、高血压以及更高的血栓栓塞事件风险。因此，各种体育组织实施了严格的规定和检测程序，以打击在竞技体育中滥用红细胞生成素的行为。 围绕红细胞生成素在体育中的使用所涉及的伦理考量突显了科学、医学与人类行为之间复杂的关系。虽然该激素可以提供合法的医疗益处，但其潜在的滥用引发了关于公平和诚信的问题。围绕红细胞生成素的讨论提醒我们在医疗保健和体育中保持伦理标准的重要性。 总之，红细胞生成素是一种重要的激素，对红细胞的生成及整体健康有显著影响。它在治疗贫血方面的治疗应用已经改变了患者护理，而其在体育中的滥用则引发了关于伦理和公平的持续辩论。理解红细胞生成素的双重性质使我们能够欣赏它对医学的贡献，同时保持对其潜在滥用的警惕。随着研究的不断发展，必须在利用红细胞生成素的益处和确保其在各个领域的负责任使用之间找到平衡。